Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1959 1
1963 1
1973 1
1975 2
1976 1
1977 1
1978 2
1979 2
1980 1
1981 1
1983 2
1984 1
1985 1
1986 3
1987 2
1988 2
1989 1
1990 7
1991 3
1992 1
1993 5
1994 6
1995 3
1996 3
1997 1
1998 1
2000 2
2001 2
2002 1
2003 2
2004 3
2005 6
2006 1
2007 5
2008 5
2009 3
2010 6
2011 4
2012 5
2013 9
2014 3
2015 8
2016 7
2017 5
2018 3
2019 3
2020 3
2021 8
2022 11
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD2 and Releasing Inducible IL-18.
Glienke W, Dragon AC, Zimmermann K, Martyniszyn-Eiben A, Mertens M, Abken H, Rossig C, Altvater B, Aleksandrova K, Arseniev L, Kloth C, Stamopoulou A, Moritz T, Lode HN, Siebert N, Blasczyk R, Goudeva L, Schambach A, Köhl U, Eiz-Vesper B, Esser R. Glienke W, et al. Among authors: esser r. Front Immunol. 2022 Mar 24;13:839783. doi: 10.3389/fimmu.2022.839783. eCollection 2022. Front Immunol. 2022. PMID: 35401506 Free PMC article.
Cetuximab every 2 weeks versus standard weekly dosing administration schedule.
Bokemeyer C, Ciardiello F, Dubreuil O, Guigay J, Kasper S, Pfeiffer P, Pinto C, Yamaguchi K, Yoshino T, Zielinski C, Esser R, Tabernero J. Bokemeyer C, et al. Among authors: esser r. Future Oncol. 2024 Mar;20(7):393-407. doi: 10.2217/fon-2023-0282. Epub 2023 Oct 18. Future Oncol. 2024. PMID: 37850363 Free article. Review.
Advantages and applications of CAR-expressing natural killer cells.
Glienke W, Esser R, Priesner C, Suerth JD, Schambach A, Wels WS, Grez M, Kloess S, Arseniev L, Koehl U. Glienke W, et al. Among authors: esser r. Front Pharmacol. 2015 Feb 12;6:21. doi: 10.3389/fphar.2015.00021. eCollection 2015. Front Pharmacol. 2015. PMID: 25729364 Free PMC article. Review.
Brain Responses during the Anticipation of Dyspnea.
Stoeckel MC, Esser RW, Gamer M, Büchel C, von Leupoldt A. Stoeckel MC, et al. Among authors: esser rw. Neural Plast. 2016;2016:6434987. doi: 10.1155/2016/6434987. Epub 2016 Aug 28. Neural Plast. 2016. PMID: 27648309 Free PMC article.
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer.
Bourhis J, Stein A, Paul de Boer J, Van Den Eynde M, Gold KA, Stintzing S, Becker JC, Moran M, Schroeder A, Pennock G, Salmio S, Esser R, Ciardiello F. Bourhis J, et al. Among authors: esser r. Cancer Treat Rev. 2021 Jun;97:102172. doi: 10.1016/j.ctrv.2021.102172. Epub 2021 Mar 2. Cancer Treat Rev. 2021. PMID: 33989949 Free article. Review.
152 results